DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Lesinurad

Lesinurad

  • Zurampic (Lesinurad)

    Zurampic (Lesinurad)

  • New Therapeutic Agents Marketed in 2015: Part 4 Amy M

    New Therapeutic Agents Marketed in 2015: Part 4 Amy M

  • Stems for Nonproprietary Drug Names

    Stems for Nonproprietary Drug Names

  • Lesinurad Cuts Uric Acid in Refractory Gout

    Lesinurad Cuts Uric Acid in Refractory Gout

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • Zurampic, INN-Lesinurad

    Zurampic, INN-Lesinurad

  • Prontuario Terapeutico Ospedale / Territorio Regionale O NC (PTOR) - XIX Edizione 3° Aggiornamento 2018

    Prontuario Terapeutico Ospedale / Territorio Regionale O NC (PTOR) - XIX Edizione 3° Aggiornamento 2018

  • Gout Guideline Supplementary Appendix 8 – Evidence Report

    Gout Guideline Supplementary Appendix 8 – Evidence Report

  • AHRQ Healthcare Horizon Scanning System – Status Update Horizon

    AHRQ Healthcare Horizon Scanning System – Status Update Horizon

  • Modulation of Urate Transport by Drugs

    Modulation of Urate Transport by Drugs

  • Zurampic: EPAR – Product Information

    Zurampic: EPAR – Product Information

  • Duzallo (Lesinurad/Allopurinol) – New Drug Approval

    Duzallo (Lesinurad/Allopurinol) – New Drug Approval

  • Lesinurad Combined with Allopurinol

    Lesinurad Combined with Allopurinol

  • Efficacy and Safety During Extended

    Efficacy and Safety During Extended

  • (Zurampic), Lesinurad/Allopurinol (Duzallo) Reference Number: ERX.NPA.75 Effective Date: 09.01.18 Last Review Date: 08.18 Revision Log

    (Zurampic), Lesinurad/Allopurinol (Duzallo) Reference Number: ERX.NPA.75 Effective Date: 09.01.18 Last Review Date: 08.18 Revision Log

  • 2020 American College of Rheumatology Guideline for the Management of Gout

    2020 American College of Rheumatology Guideline for the Management of Gout

  • Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018

    Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018

  • Australian Public Assessment Report for Lesinurad

    Australian Public Assessment Report for Lesinurad

Top View
  • Antigout Agents
  • Lesinurad in Combination with Febuxostat in Patients With
  • Zurampic), Lesinurad/Allopurinol (Duzallo
  • Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: an Evidence-Based Update
  • Annrheumdis-2016-209213.Full.Pdf
  • Antigout Agents
  • Pharmacology and Toxicology
  • Gout Guideline Supplementary Appendix 6 – Network Meta
  • Zurampic), Lesinurad/Allopurinol (Duzallo
  • ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
  • New Drugs Reviewed by CPG May 16, 2016
  • URAT1 Inhibitor Prior Authorization and Quantity Limit Criteria Program
  • Recent Advances in Understanding and Managing Gout[Version 1; Peer
  • Product Information for Lesinurad
  • Zurampic, INN-Lesinurad
  • Cross Discipline Team Leader Review
  • Generic: Sumatriptan Oral Tablets/Injection
  • FDA Briefing Document


© 2024 Docslib.org    Feedback